AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Ziglim-MV 1 Tablet SR

Prescription Icon
Prescription Required

Marketer

FDC Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Ziglim-MV 1 Tablet SR

Diabex-Duo, a single-dose sustained-release tablet, is classified as an antidiabetic medication. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose concentrations. Diabex-Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your glycemic response. Continuous use is crucial, even with well-controlled blood sugar; abrupt cessation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is a component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes management. The most frequent adverse reaction to Diabex-Duo is hypoglycemia (low blood sugar). Learn to recognize its symptoms – sweating, lightheadedness, cephalgia, and tremors – and appropriate countermeasures. Consistent meal timing and carrying readily-available glucose, like sugary snacks or fruit juice, is preventative. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is a possible consequence for some individuals. Contraindications include type 1 diabetes mellitus, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment, as Diabex-Duo may be unsuitable. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is mandatory, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Ziglim-MV 1 Tablet SR

Managing type 2 diabetes

Major Benefits of Ziglim-MV 1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Ziglim-MV 1 Tablet SR on an empty stomach.

Common Side effects of Ziglim-MV 1 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Ziglim-MV 1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Ziglim-MV 1 Tablet SR on an empty stomach.

How Ziglim-MV 1 Tablet SR works:

One extended-release Ziglim-MV tablet contains a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Ziglim-MV 1 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ziglim-MV 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Ziglim-MV tablet (1 mg) is likely not safe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Ziglim-MV 1 Tablet SR is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, its use is contraindicated in patients experiencing severe kidney disease.

LiverLiverCAUTION

Exercise caution when prescribing Ziglim-MV 1 Tablet SR to individuals with hepatic impairment. Dosage modification of Ziglim-MV 1 Tablet SR may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate Ziglim-MV 1 Tablet SR therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Ziglim-MV 1 Tablet SR :

Should you forget to take a Ziglim-MV 1 Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ziglim-MV 1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Ziglim-MV 1 Tablet SR

Ziglim-MV 1 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 DM.
Ziglim-MV 1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infection.
Ziglim-MV 1 Tablet SR is contraindicated in patients with known allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Ziglim-MV 1 Tablet SR is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Ziglim-MV 1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Ziglim-MV 1 Tablet SR
61
MRP 70
13% off